Eli Lilly downplays CVS move to drop Zepbound coverage, shares plunge
reuters.com/business/healthcare-pharmaceuticals/eli-lilly-beats-q1-profit-estimates-strength-diabetes-drug-2025-05-01
This story appeared on reuters.com, 2025-05-01 18:28:07.981000.